​

Enliven Therapeutics Ownership | Who Owns Enliven Therapeutics?

OverviewForecastFinancialsChart

Enliven Therapeutics Ownership Summary

Enliven Therapeutics is owned by 102.81% institutional investors, 6.42% insiders.

ELVN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEnliven Therapeutics102.81%6.42%-9.23%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241129.80%49,623,7144.06%1021.05%6611.86%254.17%
Sep 30, 20241028.51%47,688,348-1.31%980.98%59-14.49%2484.62%
Jun 30, 20249430.56%48,320,2788.69%1000.90%6972.50%13-40.91%
Mar 31, 20247218.03%44,456,33613.99%1051.18%4029.03%2269.23%
Dec 31, 202361-1.61%39,000,634-0.19%941.05%316.90%13-40.91%

Recent Insider Transactions

DateNameRoleActivityValue
Apr 07, 2025Patel Anish CHIEF OPERATING OFFICERSell$66.89K
Apr 07, 2025Patel Anish CHIEF OPERATING OFFICERSell$2.85K
Apr 07, 2025Patel Anish CHIEF OPERATING OFFICERSell$50.53K
Mar 27, 2025Hohl Benjamin CHIEF FINANCIAL OFFICERSell$69.32K
Mar 24, 2025Hohl Benjamin CHIEF FINANCIAL OFFICERSell$22.50K

Insider Transactions Trends

DateBuySell
2025 Q2-3
2025 Q1-14
2024 Q4-34
2024 Q3-27
2024 Q2-49

ELVN Ownership FAQ

Who Owns Enliven Therapeutics?

Enliven Therapeutics shareholders are primarily institutional investors at 102.81%, followed by 6.42% insiders and -9.23% retail investors. The average institutional ownership in Enliven Therapeutics's industry, Biotech Stocks , is 68.48%, which Enliven Therapeutics exceeds.

Does Blackrock own Enliven Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enliven Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools